Evolutionary Hypothesis in Cell Cycle of Breast Cancer Patients: Mosaic Phases in Single Cancer Cells
DOI:
https://doi.org/10.30683/1929-2279.2022.11.07Keywords:
Cell cycle, Mosaic Phases, evolutionary hypothesis, breast cancer, FISH, Protein expressionAbstract
Introduction: Cell cycle shapes the initiation, progression and therapeutic approaches of neoplasms. An uncontrolled cell proliferation and growth are the key characteristics of either malignant or benign tumors. The programmed check points control the transition of phases through the related barriers. Therefore, balancing the carcinogenic processes may inhibit progression and facilitate a targeted-base therapy.
Methods: The present study is performed in interphase. Detection of the Mosaic Phases (MPs) by Fluorescence In Situ Hybridization was confirmed by assaying the protein expression (PE) including immunofluorescence and flow cytometry.
Results: The novel hypothesis reflects the presence of dual and/or multi-phases, as minor clones in single cells of breast cancer (BC) patients. This finding led to initiate a model with applicable ratio values and different MPs including G1/S, S/G2 and G1/S/G2, accompanied by normal phases (G1, S, G2). The remarkable harmonic behaviors between signal copy numbers and the corresponding PE, dual- and triple- co-expression between different cyclins combination including E/B1 and D1/E/B1 and the other involved proteins were observed. The ratio of gain to normal signals appeared to be a good prognosis for chromosome 1, but better survival was significantly obtained for this ratio in chromosome 3
Conclusion: The predisposing-diagnostic-predictive-prognostic-preventive panels may lead to innovate the CDKs inhibitor-based therapy by considering the MPs Model; and may also be considered for clinical classification, in BC and other cancers.
References
Belanger H, Beaulieu P, Moreau C, Labuda D, Hudson TJ, Sinnett D. Functional Promoter SNPs in Cell Cycle Checkpoint Genes. Human Molecular Genetics 2005; 4: 2641-8. https://doi.org/10.1093/hmg/ddi298
Dickson MA. Molecular pathways: CDK4 inhibitors for cancer therapy. Clinical Cancer Research 2014; 20: 3379-3383. https://doi.org/10.1158/1078-0432.CCR-13-1551
Dalton S. Linking the cell cycle to cell fate decisions. Trends in Cell Biology 2015; 25: 592-600. https://doi.org/10.1016/j.tcb.2015.07.007
Turnbull C, Ahmed S, Morrison J, Pernet D, Renwick A, Maranian M, Seal S, Ghoussaini M, Hines S, Healey CS, Hughes D. Genome-wide association study identifies five new BC susceptibility loci. Nature Genetics 2010; 42: 504-507. https://doi.org/10.1038/ng.586
Siegel PM, Hardy WR, Muller WJ. Mammary gland neoplasia: insights from transgenic mouse models. Bioessays 2000; 22: 554-563. https://doi.org/10.1002/(SICI)1521-1878(200006)22:6<554::AID-BIES8>3.0.CO;2-A
Salmon ES, Sartorelli AC. Cancer Chemotherapy. In: Katzung. BG, editor. Basic & Clinical Phamacology, Appleton & Lange. UK: 1998; 881-915.
Santamaria D, Barriere C, Cerqueira A, et al. Cdk1 is sufficient to drive the mammalian cell cycle. Nature 2007; 448: 811-815. https://doi.org/10.1038/nature06046
Schwanitz G, Raff R. Application of specific cytologic, cytogenetic and molecular-cytogenetic techniques for the characterization of solid tumors. Annales Academiae Medicae Bialostocensis 2005; 50: 91-96.
Therman Eva. Human chromosomes, structure, behavior, effects.2nd ed. Heidelberg: Springer-Verlag, 1986; 273-281. https://doi.org/10.1007/978-1-4684-0269-8_27
White MJD. Mitotic cycle. In: Human chromosomes, structure, behavior, effects. 2nd ed. Heidelberg: Springer-Verlag,Therman E, editor, 1986; 28-29.
Mehdipour P, Pirouzpanaha S, Sarafnejad A, Atri M Shahrestani T, Haidari M. Prognostic implication of CDC25A and cyclin E expression on primary BC patients. Cell Biology International 2009; 33: 1050-1056. https://doi.org/10.1016/j.cellbi.2009.06.016
Sandberg AA. The chromosomes in human cancer and leukemia. 1st ed. New York: Elsevier 1980; 75.
Miklos GLG, John B. Heterochromatin and satellite DNA in man: properties and prospects. Am J Hum Genet 1979; 31: 264-280.
Wilson EB. The cell in development and heredity. 3rd editor. New York: McMillian, 1925.
Kyte J, Doolittle RFA. simple method for displaying the hydropathic character of a protein. J Mol Biol 1982; 157: 105-32. https://doi.org/10.1016/0022-2836(82)90515-0
Flavell RB. Sequence amplification, deletion and rearrangement:Major source of variation during species of divergence, 1982. In: Therman E, editor. Human chromosomes, structure, behavior, effects.2nd edn. Heidelberg: Springer-Verlag, 1986; 52-57.
Miklos GLG, Amanda Clare Gill AC. Sequencing and of high repeated DNA. Compilation and Comments 1982; 39: 1-30. https://doi.org/10.1017/S0016672300020711
Therman E, Kuhn EM. Mitotic modifications and aberrations in cancer. CRC. Crit Rev Oncogen 1989; 1: 293-305.
Lodisch H, Berk A, Zipursky SL, Matsudaira P, Baltimore D, Darnell J, Eds. Molecular cell Biology. New York: Media Connected, 2000; 524-526.
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
Similar Articles
- Parvin Mehdipour, Asaad Azarnezha, Eight-Hit Evolutionary Pattern in ATM Gene of a Breast Carcinoma Patient: A Personalized Approach , Journal of Cancer Research Updates: Vol. 10 (2021)
- Jiangting Hu, Ern Yu Tan, Leticia Campo, Russell Leek, Zainina Seman, Helen Turley, Domenico Delia, Alfredo Cesario, Kevin Gatter, Francesco Pezzella, TRAP1 is Involved in Cell Cycle Regulated by Retinoblastoma Susceptibility Gene (RB1) in Early Hypoxia and has Variable Expression Patterns in Human Tumors , Journal of Cancer Research Updates: Vol. 2 No. 3 (2013)
- Parvin Mehdipour, Multi-Phase Based Signature and Cancer Management: An Insight in Embryo, Brain Tumor, Leukemia, and Von Hippel Lindau Syndrome , Journal of Cancer Research Updates: Vol. 12 (2023)
- Maria Teresa Piccolo, Stefania Crispi, The Dual Role Played by p21 May Influence the Apoptotic or Anti-Apoptotic Fate in Cancer , Journal of Cancer Research Updates: Vol. 1 No. 2 (2012)
- Dhafer A. Alghezi, Rasha Aljawher, Hameed Naeem Mosa, Increased KI67 Immunostaining is Associated with Breast Cancer Aggressiveness , Journal of Cancer Research Updates: Vol. 14 (2025)
- Sung-Han Hsiao, Shi-Yu Luo, Ching-Ya Su, Wei-Cherng Tuo, Cheng-Ting Chiang, Yan-Qing Li, Yang-Hui Huang, Chung-Pu Wu, The Overexpression of ABCG2 Reduces the Efficacy of Volasertib (BI 6727) and GSK641364 in Human S1-M1-80 Colon Carcinoma Cells , Journal of Cancer Research Updates: Vol. 3 No. 2 (2014)
- Ana-Matea Mikecin, Mira Grdisa, TAT-Mediated Delivery of p27 in Tumor Cell Lines as a Potential Therapeutic Peptide , Journal of Cancer Research Updates: Vol. 1 No. 1 (2012)
- Nur Syahada Ab Razak, Nadiah Abu, Chemotherapy-Associated Extracellular Vesicles Modulate T Cells Activity and Cytokine Release , Journal of Cancer Research Updates: Vol. 13 (2024)
- Jian-Yang Hu, Min-Feng Chen, Xue-Ping Lei, Zhen-Jian Zhuo, Hai-Yan Sun, Zhe-Sheng Chen, Zhi Shi, Dong-Mei Zhang, Wen-Cai Ye, Bufalin Induces Apoptosis of MDA-MB-231 Cell Through Activation of JNK/p53 Pathway , Journal of Cancer Research Updates: Vol. 4 No. 2 (2015): Special Issue - Natural Products for Cancer Prevention and Treatment
- Sandip K. Mishra, K. Kanchan, Dharmendra K. Bhargava, A Review on EZH2 and its Epigenetic Association with Breast Cancer , Journal of Cancer Research Updates: Vol. 1 No. 2 (2012)
You may also start an advanced similarity search for this article.
Most read articles by the same author(s)
- Parvin Mehdipour, Asaad Azarnezha, Eight-Hit Evolutionary Pattern in ATM Gene of a Breast Carcinoma Patient: A Personalized Approach , Journal of Cancer Research Updates: Vol. 10 (2021)
- Parvin Mehdipour, Multi-Phase Based Signature and Cancer Management: An Insight in Embryo, Brain Tumor, Leukemia, and Von Hippel Lindau Syndrome , Journal of Cancer Research Updates: Vol. 12 (2023)